Application Nr Approved Date Route Status External Links
NDA021569 2006-07-27 Intravascular RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage 50 Ml Syringe: Sodium Chloride Injection Usp 0.9% Is Indicated For Use In Flushing Compatible Contrast Agents Through Mallinckrodt Intravenous Administration Sets Into Indwelling Intravascular Access Devices When Delivered Manually Or By The Following Mallinckrodt Power Injectors: Optistar™ Le And Optistar™ Elite™. 125 Ml Syringe: Sodium Chloride Injection Usp 0.9% Is Indicated For Use In Flushing Compatible Contrast Agents Through Mallinckrodt Intravenous Administration Sets Into Indwelling Intravascular Access Devices Only When Delivered By The Following Mallinckrodt Power Injectors: Angiomat™, Illumena™, Ct9000™, Ct9000™ Adv, Optistat™, Optivantage™ And Optistar Elite. For Use In Flushing Compatible Contrast Agents Through Mallinckrodt Intravenous Administration Sets Into Indwelling Intravascular Access Devices (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Sodium Chloride

Comments